AG真人官方

MSP Recovery Announces Reverse Stock Split to Maintain Compliance with Nasdaq鈥檚 Minimum Bid Price Requirement

MSP Recovery鈥檚 Common Stock Will Begin Trading on Split-Adjusted Basis on Tuesday, September 2, 2025

MIAMI, Aug. 28, 2025 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ: MSPR) (the聽鈥淐ompany鈥�), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announces that it will affect a reverse stock split of its Class A common stock at a reverse stock split ratio of 1-for-7, effective at 11:59 P.M. on September 1, 2025, in order to maintain compliance with the minimum $1.00 bid price per share requirement of Nasdaq鈥檚 Marketplace Rule 5450(a)(1).

The Company鈥檚 Common Stock will continue to trade on the Nasdaq Capital Market (鈥淣asdaq鈥�) under the symbol 鈥淢SPR鈥� and will begin trading on a split-adjusted basis when the Nasdaq opens on September 2, 2025 (鈥淓ffective Time鈥�). The new CUSIP number for the Company鈥檚 Class A common stock following the reverse split will be 553745-40-7.

The Company鈥檚 stockholders previously approved the reverse stock split and granted the Company鈥檚 board of directors the authority to determine the final reverse stock split ratio and when to proceed with the reverse stock split. The Company has filed an amendment to its Second Amended and Restated Certificate of Incorporation to affect the reverse stock split at the ratio of 1-for-7, as of the Effective Time.

As a result of the reverse split, every seven (7) shares of the Company鈥檚 issued and outstanding Common Stock will automatically be converted into one share of issued and outstanding Common Stock. The Company鈥檚 shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing upon market open on September聽2,聽2025. Immediately after the reverse split becomes effective, there will be approximately 1.02 million shares of Class A common stock issued and outstanding.

About MSP Recovery

Founded in 2014, MSP Recovery has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries from responsible parties. MSP Recovery innovates technologies and provides comprehensive solutions for multiple industries including healthcare and legal. For more information, visit: msprecovery.com.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as 鈥渁nticipate,鈥� 鈥渂elieve,鈥� 鈥渆xpect,鈥� 鈥渋ntend,鈥� 鈥減lan,鈥� and 鈥渨ill鈥� or, in each case, their negative, or other variations or comparable terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance or results and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by MSP Recovery herein speaks only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for the Company to predict or identify all such events or how they may affect it. MSP Recovery has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, the Company鈥檚 ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; the inability of MSP Recovery to obtain financing and generate revenues sufficient to cover the cost of operations; the inherent uncertainty surrounding settlement negotiations and/or litigation, including with respect to both the amount and timing of any such results; the validity of the assignments of claims to MSP Recovery; the ability to successfully expand the scope of the Company鈥檚 claims or obtain new data and claims from the Company鈥檚 existing assignor base or otherwise; the Company鈥檚 ability to innovate and develop new solutions, and whether those solutions will be adopted by the Company鈥檚 existing and potential assignors; negative publicity concerning healthcare data analytics and payment accuracy; and those additional factors included in MSP Recovery鈥檚 Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by it with the Securities and Exchange Commission. These statements constitute the Company鈥檚 cautionary statements under the Private Securities Litigation Reform Act of 1995.

For Media Inquiries:

For Investor Inquiries: